Gemcitabine (1000 mg/m2): clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

9

Conditions studied

17

US states with sites

4

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Conditions being studied

Condition	Trials
Gastric Cancer	1
Head and Neck Cancer	1
Lung cancer	1
Melanoma	1
Non-Small Cell Lung Cancer	1
Renal Cell Carcinoma	1
Resectable Non-Small-Cell Lung Cancer	1
Solid Tumor	1
Urothelial Carcinoma	1

Recruiting trials involving Gemcitabine (1000 mg/m2)

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
NCT04198766 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 42 locations

Common questions

How many recruiting trials involve Gemcitabine (1000 mg/m2)?

1 recruiting trial across 9 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.